MAVERICK CAPITAL LTD - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 149 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.

Quarter-by-quarter ownership
MAVERICK CAPITAL LTD ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,578,283
-8.1%
6,471,8130.0%0.22%
-2.7%
Q2 2023$10,419,619
-45.1%
6,471,813
-1.1%
0.22%
-53.8%
Q1 2023$18,981,698
-8.0%
6,545,413
+4.0%
0.48%
-1.6%
Q4 2022$20,634,523
-30.5%
6,291,013
-19.9%
0.49%
-26.9%
Q3 2022$29,695,000
-51.5%
7,855,8240.0%0.67%
-55.7%
Q2 2022$61,197,000
-16.1%
7,855,8240.0%1.51%
+17.9%
Q1 2022$72,981,000
-41.1%
7,855,8240.0%1.28%
-8.4%
Q4 2021$123,808,000
-12.0%
7,855,8240.0%1.40%
-1.3%
Q3 2021$140,619,000
+17.4%
7,855,824
+2.0%
1.42%
+26.0%
Q2 2021$119,808,000
+23.8%
7,704,676
+14.3%
1.12%
+26.1%
Q1 2021$96,778,000
-32.7%
6,739,402
-8.0%
0.89%
-61.3%
Q4 2020$143,781,000
+64.4%
7,324,539
+8.6%
2.30%
+41.7%
Q3 2020$87,432,000
-11.2%
6,746,292
-0.1%
1.62%
-21.5%
Q2 2020$98,407,000
+122.4%
6,754,102
+29.9%
2.07%
+121.6%
Q1 2020$44,251,000
-45.8%
5,199,897
+4.9%
0.93%
-21.4%
Q4 2019$81,665,000
+13.3%
4,958,431
-2.9%
1.19%
+12.3%
Q3 2019$72,068,000
+60.5%
5,103,963
+128.6%
1.06%
+62.7%
Q2 2019$44,895,000
+29.7%
2,232,476
+156.4%
0.65%
+41.8%
Q1 2019$34,613,000870,7640.46%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
KPCB XV Associates, LLC 1,876,650$29,182,00013.03%
Copernicus Capital Management, LLC 50,000$778,00012.27%
Antipodean Advisors LLC 1,000,000$15,550,0004.28%
BRIDGER MANAGEMENT, LLC 1,325,188$20,607,0001.92%
Redmile Group, LLC 6,449,577$100,291,0001.48%
MAVERICK CAPITAL LTD 7,704,676$119,808,0001.12%
Baupost Group 8,477,488$131,825,0001.07%
ACT CAPITAL MANAGEMENT, LLC 116,900$1,818,0000.93%
Trellus Management Company, LLC 73,056$1,136,0000.78%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$8,164,0000.75%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders